{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:48:39Z","timestamp":1795085319579,"version":"4.10.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1136\/ijgc-2019-000287","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T10:53:41Z","timestamp":1562237621000},"page":"1164-1169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Liat","family":"Hogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vicus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Elizabeth","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian T","family":"Gien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Nofech-Mozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve K","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Q","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000287_bb0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/IGC.0b013e3181dd0110","article-title":"Prognostic relevance of uncommon ovarian histology in women with stage III\/IV epithelial ovarian cancer","volume":"20","author":"Mackay","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jog.12360","article-title":"Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013","volume":"40","author":"Aoki","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1136\/ijgc-2019-000287_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/IGC.0b013e3181991546","article-title":"Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial","volume":"19","author":"Timmers","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/IGC.0b013e3181a83f4f","article-title":"The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study","volume":"19","author":"Takano","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0040","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2015.09.016","article-title":"Ovarian clear cell carcinoma, outcomes by stage: the MSK experience","volume":"139","author":"Shu","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2012.04.021","article-title":"Clear cell carcinoma of the ovary: a review of the literature","volume":"126","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1998.5071","article-title":"Clinical characteristics of clear cell carcinoma of the ovary","volume":"70","author":"Behbakht","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0060","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/IGC.0b013e3182540145","article-title":"Postrecurrent oncologic outcome of patients with ovarian clear cell carcinoma","volume":"22","author":"Kajiyama","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"9 Suppl 3","key":"10.1136\/ijgc-2019-000287_bb0070","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IGC.0000000000000289","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary","volume":"24","author":"Okamoto","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0075","first-page":"52","article-title":"Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial","volume":"16","author":"Utsunomiya","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0080","first-page":"1506","article-title":"Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study","volume":"20","author":"Takano","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0085","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2011.40.1646","article-title":"Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation","volume":"30","author":"Hoskins","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2016.09.006","article-title":"The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma","volume":"143","author":"Hogen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2006.12.024","article-title":"Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary","volume":"105","author":"Crotzer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1525-1438.2007.01158.x","article-title":"Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study","volume":"18","author":"Takano","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000287_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma","volume":"32","author":"Jenison","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2012.07.1210","article-title":"Patterns of recurrence and the role of radiation therapy in ovarian clear cell adenocarcinoma","volume":"84","author":"Macrie","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000287_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","article-title":"Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors","volume":"104","author":"Blanchard","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000287_bb0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2009.11.008","article-title":"The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study","volume":"116","author":"Gadducci","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:24:11Z","timestamp":1753233851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24002561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1048891X24002561"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000287","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2019-000287.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2019-000287.supp2","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}